If standard treatments haven’t worked, don’t lose hope. Discover what treatment-resistant bipolar disorder means and new ...

Uzedy administered once every 2 months is not recommended for the maintenance treatment of bipolar I disorder. The Food and Drug Administration (FDA) has approved Uzedy ® (risperidone extended-release ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best high volume stocks to buy according to Wall Street ...

After losing nearly all my friends, I discovered how unmanaged bipolar symptoms were sabotaging my relationships — and how I ...

The FDA expanded the approval of once-monthly risperidone (Uzedy) to include adjunct treatment for bipolar I disorder, ...

An imbalance in the gut microbiome has been found to contribute to inflammation, immune system dysfunction and the production of harmful metabolites.

The first under-the-skin, long-acting risperidone injection offers a new maintenance option for adults with bipolar 1 ...

Moment of Clarity has released a new resource titled “Is Spravato Covered by Insurance?“, now available on their website. The ...

Immigrants allege ICE used full-body WRAP restraints during deportations, sparking lawsuits and civil rights concerns over ...